Skip Navigation

COVID-19: We are vaccinating patients ages 12+. Learn more:

Vaccines, Boosters & 3rd Doses | Testing | Patient Care | Visitor Guidelines | Coronavirus | Self-Checker | Email Alerts

 

Philips Respironics issued a recall for some CPAP and BiLevel PAP devices and mechanical ventilators. Learn more.

 

Type 2 Diabetes Research

Type 2 diabetes already affects 20 million Americans, and its prevalence is rising to epidemic proportions worldwide. At Hopkins, GIM research faculty, with National Institutes of Health and American Diabetes Association support, are combating diabetes across a range of fronts including clinical, social, genetic, and molecular epidemiology; health services research; psychology and health behavior; and randomized, controlled trials. Our focus is on prevention of diabetes and its complications, effective management of diabetes by development of and application of evidence-based treatment strategies, and by the identification of novel risk factors that can be modified by clinical treatment, behavior change, and/or public health policy. Hopkins GIM is proud to serve as a collaborative home for diabetes researchers across the Hopkins campus, including faculty from Endocrinology (Drs. Sherita Golden and Rita Kalyani), Cardiology (Dr. Kerry Stewart), Pathology (Dr. Mark Halushka), Physical Medicine and Rehabilitation (Dr. Pegah Touradji), and Nursing (Dr. Jerilyn Allen)

Return to Hopkins GIM Research section    

back to top button